Skip to content

Clinical trials

Phase 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 3 Country / region: United States Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20031
20051
20062
20073
20081
20103
20121
20143
20161
20171
20181
20191
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated5
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Medical College of Wisconsin3
Fred Hutchinson Cancer Center2
Pfizer2
St. Jude Children's Research Hospital2
Alliance for Clinical Trials in Oncology1
Ariad Pharmaceuticals1
Ascentage Pharma Group Inc.1
Bristol-Myers Squibb1
Case Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive28
Leukemia, Myeloid, Acute10
Leukemia9
Myelodysplastic Syndromes9
Precursor Cell Lymphoblastic Leukemia-Lymphoma9
Leukemia, Myeloid, Chronic-Phase6
Myeloproliferative Disorders6
Lymphoma5
Bone Marrow Diseases4
Hematologic Neoplasms4

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.